RX-224

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRX-224
Drug Alias NameRX-224
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycosaminoglycan inhibitors
TargetsGlycosaminoglycan
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRimonyx Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRimonyx Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsInflammation

Other Information

ATC CodeN/A
Related LinksN/A